These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 34854399)

  • 1. Adult hypophosphatasia treated with reduced frequency of teriparatide dosing.
    Polyzos SA; Tournis S; Goulas A; Kollia P; Whyte MP
    J Musculoskelet Neuronal Interact; 2021 Dec; 21(4):584-589. PubMed ID: 34854399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ADULT HYPOPHOSPHATASIA TREATED WITH TERIPARATIDE: REPORT OF 2 PATIENTS AND REVIEW OF THE LITERATURE.
    Camacho PM; Mazhari AM; Wilczynski C; Kadanoff R; Mumm S; Whyte MP
    Endocr Pract; 2016 Aug; 22(8):941-50. PubMed ID: 27042741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adult hypophosphatasia treated with teriparatide.
    Whyte MP; Mumm S; Deal C
    J Clin Endocrinol Metab; 2007 Apr; 92(4):1203-8. PubMed ID: 17213282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of adult hypophosphatasia with teriparatide.
    Camacho PM; Painter S; Kadanoff R
    Endocr Pract; 2008 Mar; 14(2):204-8. PubMed ID: 18308659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of sustained response to teriparatide in a patient with adult hypophosphatasia.
    Gagnon C; Sims NA; Mumm S; McAuley SA; Jung C; Poulton IJ; Ng KW; Ebeling PR
    J Clin Endocrinol Metab; 2010 Mar; 95(3):1007-12. PubMed ID: 20089612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of ALPL variant states and clinical outcomes: An analysis of adults and adolescents with hypophosphatasia treated with asfotase alfa.
    Kishnani PS; Del Angel G; Zhou S; Rush ET
    Mol Genet Metab; 2021 May; 133(1):113-121. PubMed ID: 33814268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone turnover and mineral metabolism in adult patients with hypophosphatasia treated with asfotase alfa.
    Seefried L; Rak D; Petryk A; Genest F
    Osteoporos Int; 2021 Dec; 32(12):2505-2513. PubMed ID: 34215909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Teriparatide treatment in an adult patient with hypophosphatasia exposed to bisphosphonate and revealed by bilateral atypical fractures.
    Righetti M; Wach J; Desmarchelier R; Coury F
    Joint Bone Spine; 2018 May; 85(3):365-367. PubMed ID: 29246529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Asfotase Alfa on Muscle Weakness in a Japanese Adult Patient of Hypophosphatasia with Low ALP Levels.
    Koyama H; Yasuda S; Kakoi S; Ohata Y; Shimizu Y; Hasegawa C; Hayakawa A; Akiyama T; Yagi T; Aotani D; Imaeda K; Ozono K; Kataoka H; Tanaka T
    Intern Med; 2020 Mar; 59(6):811-815. PubMed ID: 31787692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parathyroid hormone treatment improves pain and fracture healing in adult hypophosphatasia.
    Schalin-Jäntti C; Mornet E; Lamminen A; Välimäki MJ
    J Clin Endocrinol Metab; 2010 Dec; 95(12):5174-9. PubMed ID: 20739387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone mineral density and fracture risk in adult patients with hypophosphatasia.
    Genest F; Claußen L; Rak D; Seefried L
    Osteoporos Int; 2021 Feb; 32(2):377-385. PubMed ID: 32879991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypophosphatasia: presentation and response to asfotase alfa.
    Alsarraf F; Ali DS; Almonaei K; Al-Alwani H; Khan AA; Brandi ML
    Osteoporos Int; 2024 Apr; 35(4):717-725. PubMed ID: 37993691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone healing and reactivation of remodeling under asfotase alfa therapy in adult patients with pediatric-onset hypophosphatasia.
    Stürznickel J; Schmidt FN; von Vopelius E; Delsmann MM; Schmidt C; Jandl NM; Oheim R; Barvencik F
    Bone; 2021 Feb; 143():115794. PubMed ID: 33301963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Atypical femoral fractures" during bisphosphonate exposure in adult hypophosphatasia.
    Sutton RA; Mumm S; Coburn SP; Ericson KL; Whyte MP
    J Bone Miner Res; 2012 May; 27(5):987-94. PubMed ID: 22322541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement of bone microarchitecture parameters after 12 months of treatment with asfotase alfa in adult patient with hypophosphatasia: Case report.
    Freitas TQ; Franco AS; Pereira RMR
    Medicine (Baltimore); 2018 Nov; 97(48):e13210. PubMed ID: 30508901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypophosphatasia: From Diagnosis to Treatment.
    Simon S; Resch H; Klaushofer K; Roschger P; Zwerina J; Kocijan R
    Curr Rheumatol Rep; 2018 Sep; 20(11):69. PubMed ID: 30203264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asfotase alfa treatment for 1 year in a 16 year-old male with severe childhood hypophosphatasia.
    Bowden SA; Adler BH
    Osteoporos Int; 2018 Feb; 29(2):511-515. PubMed ID: 29046930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Japanese single-center experience of the efficacy and safety of asfotase alfa in pediatric-onset hypophosphatasia.
    Sugiyama Y; Watanabe T; Tajika M; Matsuhashi T; Shimura M; Fushimi T; Ichimoto K; Matsunaga A; Ebihara T; Tsuruoka T; Akiyama T; Murayama K
    Orphanet J Rare Dis; 2022 Feb; 17(1):78. PubMed ID: 35197081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Five-year efficacy and safety of asfotase alfa therapy for adults and adolescents with hypophosphatasia.
    Kishnani PS; Rockman-Greenberg C; Rauch F; Bhatti MT; Moseley S; Denker AE; Watsky E; Whyte MP
    Bone; 2019 Apr; 121():149-162. PubMed ID: 30576866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A two-year follow-up of asfotase alfa replacement in a patient with hypophosphatasia: clinical, biochemical, and radiological evaluation.
    Reis FS; Gomes DC; Arantes HP; Lazaretti-Castro M
    Arch Endocrinol Metab; 2021 May; 64(5):623-629. PubMed ID: 34033304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.